Celestone Chronodose TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: betamethasone acetate + betamethasone sodium phosphate
Brand name
(ARTG)
: CELESTONE CHRONODOSE betamethasone 5.7mg/1mL (as acetate and sodium phosphate) injection ampouleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Celestone Chronodose is indicated in the treatment of both severe and moderate conditions in acute and chronic self-limiting diseases responsive to systemic corticosteroid therapy and is especially useful in patients for whom treatment with oral corticosteroid medication is not feasible. Representative conditions: Rheumatic Disorders: rheumatoid arthritis, acute and subacute bursitis, epicondylitis, acute non-specific tenosynovitis, myositis, fibrositis, tendonitis, psoriatic arthritis. Collagen Diseases: systemic lupus erythematosus, scleroderma, dermatomyositis. Allergic States: status asthmaticus, chronic bronchial asthma, seasonal or perennial allergic rhinitis, severe allergic bronchitis, contact dermatitis, atopic dermatitis, hypersensitivity reactions to drug and insect bites. Dermatologic Conditions: localised, hypertrophic infiltrated lesions of lichen planus, psoriatic plaques, granuloma annulare and lichen simplex chronicus(neurodermatitis). keloids, discoid lupus erythematosus, necrobiosis lipoidica diabeticorum, alopecia areata. Antepartum use in the prevention of respiratory distress syndrome in premature infants when it is deemed necessary to induce labour prior to the thirty-second week of gestation becomes inevitable because of obstetric complication. Celestone Chronodose injection should also be considered for prophylactic treatment if the foetus is known to have a low lecithin/sphingomyelin ratio (or decreased foam stability test on amniotic fluid).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, suspension
- Intracavitary
- Clear colourless liquid containing easily suspendable white particles with no visible agglomerates; free from foreign matter
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 18 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 mL x 2 (sample) pack
- 1 mL x 5 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient betamethasone acetate + betamethasone sodium phosphate
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
